Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Jack Li Jie, Joe Nahra, Adam R. Johnson, Amy Bunker, Patrick O'Brien, Wen Song Yue, Daniel F. Ortwine, Chiu Fai Man, Vijay Baragi, Kenneth Kilgore, Richard D. Dyer, Hyo Kyung Han

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science